Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:02 AM
Ignite Modification Date:
2025-12-25 @ 4:02 AM
NCT ID:
NCT02451202
Eligibility Criteria:
Inclusion Criteria:
* Male or female aged 18 - 60 years; ASA I-III.
* Subjects have been planned for elective endolaryngeal. Procedures (Direct Laryngoscopy with laser (micro-)surgery in patients with Tis, T1, T2, supraglottis and glottis carcinoma)
Exclusion Criteria:
* Any renal impairment (CrCL \< 80 ml/ min)
* Any hepatic impairment; Child Pugh A, B or C
* BMI \> 30 kg m2
* Known or suspected generalized neuromuscular disorders
* Allergies to Rocuronium, Sugammadex, Sevoflurane, Propofol, fentanyl used during general anesthesia
* Hypersensitivity to the active substance or to any of the excipients
* Female patient who are pregnant and breastfeeding.
* Patient with poor Glasgow Coma Score and mental derangement who is unable to give informed consent.
* Patient with Tracheostomy tube.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT02451202
Study Brief:
Protocol Section:
NCT02451202